AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Complaint Filed With FDA Against RU486.(United States Food and Drug Administration abortion drug)(Evaluation)
A 92-page "Citizen Petition" filed with the Food and Drug Administration is asking the FDA to rescind its approval of RU486, the French abortion pill, because of safety concerns and procedural violations in the drug approval process.
The petition, formally filed on August 20, details numerous ways in which the Clinton-Gore FDA bent or broke its own rules to get the drug on the market just prior to the 2000 election. Now, nearly two years later, the release of government documents has given petitioners and the public at large the opportunity to see just how many times and ways the agency cut corners to satisfy a political constituency and put women's lives and ...
- United Therapeutics Announces FDA Approval of Expanded Label Indication and...
- Press release article from: PR Newswire March 21, 2006 700+ words
...and Drug Administration (FDA) has approved a supplemental...in satisfaction of the FDA's Subpart H accelerated approval...successfully completed our Subpart H accelerated approval...Phase 4 study results, the FDA has expanded Remodulin...
- Keryx Reaches Agreement With FDA for KRX-101 Subpart-H Plan for Diabetic Kidney...
- Press release article from: PR Newswire November 13, 2002 700+ words
Subpart H (Accelerated...Plan Designed with FDA Could Speed Drug...to market. The Subpart H clinical development...submitted to the FDA as a special protocol...guidance that the FDA has given us in...this breakthrough Subpart H program. We...
- Agreement reached with FDA for KRX-101 subpart-H plan.
- Newspaper article from: Drug Week January 3, 2003 700+ words
...it has designed a Subpart H (accelerated approval...collaboration with the FDA for KRX-101, Keryx...time to market. The Subpart H clinical development...submitted to the FDA as a special protocol...guidance that the FDA has given us in designing...this breakthrough Subpart H program. ...
- XOMA'S Neuprex for Meningococcemia Receives Subpart E Designation from FDA's...
- Press release article from: Business Wire August 6, 1996 700+ words
...has been granted a Subpart E designation for its...Evaluation and Research (FDA's CBER). This designation...open-label study. Subpart E designation is intended...Neuprex study. "The Subpart E designation also signifies recognition by the FDA that meningococcemia...
- OHRP investigator says IRB staff must know all rules, including Subparts B, C...
- Newspaper article from: BioResearch Compliance Report Pickett, Joseph September 1, 2006 700+ words
...all regulations, including Subparts B, C and D, according to...some IRB staff only knows Subpart A. "There is much more to Subpart D (clinical research involving...she said. As with following FDA regulations, the key to staying...
- Definition of 'human subjects research' under Subpart A recommended for...
- Newspaper article from: BioResearch Compliance Report Pickett, Joseph August 1, 2006 700+ words
...including the definition of "human subjects research." SACHRP's Subpart A Subcommittee (SAS) reported here July 31 that social and...The Department of Health & Human Services (DHHS) and FDA should publish in the Federal Register a revised list if expedited...
- New subpart F lookthrough rules.
- Magazine article from: The Tax Adviser Landreneau, Frank Jackson, Anjana Morrison, Richard November 1, 2006 700+ words
...multinationals involves the new subpart F lookthrough rules. On May 17...international earnings without triggering subpart F income. In general, this new provision provides an exception from the subpart F rules for dividends, interest...
- Subpart F treatment of hybrid branches and partnerships.(IRC Subpart F)
- Magazine article from: The Tax Adviser Granberg, Michael W. September 1, 1999 700+ words
...corporations (CFCs) and hybrid branches under subpart F. Notice 98-11, which announced the...covering CFCs, hybrid transactions and subpart F income. The IRS did not plan to finalize...contrary to the policies and rules of subpart E These arrangements involve the use of...
Source: HighBeam Research, Complaint Filed With FDA Against RU486.(United States Food and Drug...